NCT06104046 is a clinical trial in Hepatitis C Virus, sponsored by Assiut University.

Who is sponsoring NCT06104046?

NCT06104046 is sponsored by Assiut University.

What condition does NCT06104046 study?

NCT06104046 studies Hepatitis C Virus.

Is NCT06104046 still recruiting?

NCT06104046 is currently status unknown. Last updated 27 October 2023.

Last reviewed 2023-10-27 · How we verify

NCT06104046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

Status unknown Last updated 27 October 2023

What this trial tests

trial in Hepatitis C Virus in 50 participants. Status unknown.

Timeline

26 October 2023

Primary endpoint
31 December 2024

31 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	26 October 2023
Primary completion	31 December 2024
Estimated completion	31 March 2025

Conditions studied

Hepatitis C Virus — all drugs for Hepatitis C Virus →

Sponsor

Assiut University

Who can join

Adults 1 to 18, any sex, with Hepatitis C Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

observational cross sectional study for children with chronic kidney disease who on regular hemodialysis in assiut univeristy children hospital at dialysis unit, observe prevalence of serological seroconversion of hepatitis c virus and associated risk factors

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children.
Jarasvaraparn C, Hartley C, Karnsakul W. · · 2024 · cited 6× · PMID 38392918 · DOI 10.3390/pathogens13020180

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06104046 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 27 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06104046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing